[Kyunghyang Shinmun] March 21, 2018


Miracell, a stem cell company, announced on the 21st that it has expanded its stem cell storage business by partnering with Smart Stem Cell, Inc., following its partnership with the International Mira Stem Cell Bank.
This cell banking business encompasses stem cells, immune cells, and the growth factors they secrete, isolated from blood, bone marrow, and adipose tissue.
A company representative stated, “Its unique characteristics include its superior cell recovery rate and the concentration of beneficial growth factors.”
“We have developed a program that can predict and manage disease and aging through DNA analysis, cell health testing, biological age testing, and telomere (the end of chromosomes) testing.”
Cell banking refers to storing healthy cells, similar to depositing them in a bank. If a patient develops cancer, their own cells can be used for treatment.
This is one of the ethically sound regenerative treatments. The cell banking storage period is approximately 30 to 40 years.
Miracell has established a system in collaboration with hospitals nationwide to ensure that cells can be used at any time after banking. A company representative said, “Recently, Miracell has been receiving visits from countries such as Thailand, Vietnam, Hong Kong, Indonesia, and China, expressing great interest in Miracell’s cell storage business.”
Reporter Park Hyo-sun anytoc@kyunghyang.com